Neoadjuvant Atezolizumab in Surgically Resectable Advanced Cutaneous Squamous Cell Carcinoma
Status:
Recruiting
Trial end date:
2024-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this research is to evaluate whether the administration of atezolizumab before
surgical resection of your tumor is feasible and to evaluate the treatment response, safety,
and tolerability of atezolizumab.